$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Generation of Gene-Modified T Cells Reactive against the Angiogenic Kinase Insert Domain-Containing Receptor (KDR) Found on Tumor Vasculature

Human gene therapy, v.11 no.18, 2000년, pp.2445 - 2452  

Kershaw, Michael H. (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892) ,  Westwood, Jennifer A. (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892) ,  Zhu, Zhenping (Department of Molecular and Cell Biology, ImClone Systems, New York, NY 10014) ,  Witte, Larry (Department of Molecular and Cell Biology, ImClone Systems, New York, NY 10014) ,  Libutti, Steven K. (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892) ,  Hwu, Patrick (Tumor Immunology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892)

Abstract AI-Helper 아이콘AI-Helper

The destruction of newly forming tumor vasculature is a promising approach to inhibit tumor growth. The goal of the present study was to investigate whether human lymphocytes gene modified to express a chimeric receptor specific for the angiogenic endothelial cell receptor, KDR, could react against ...

참고문헌 (36)

  1. Aiello, L P, Pierce, E A, Foley, E D, Takagi, H, Chen, H, Riddle, L, Ferrara, N, King, G L, Smith, L E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.. Proceedings of the National Academy of Sciences of the United States of America, vol.92, no.23, 10457-10461.

  2. Baggiolini, Marco, Dewald, Beatrice, Moser, Bernhard. HUMAN CHEMOKINES:An Update. Annual review of immunology, vol.15, 675-705.

  3. Baldwin, Gayle Cocita. The biology of granulocyte-macrophage colony-stimulating factor: Effects on hematopoietic and nonhematopoietic cells. Developmental biology, vol.151, no.2, 352-367.

  4. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. The Journal of experimental medicine, vol.173, no.3, 647-658.

  5. Am. J. Pathol. BROWN L.F. 1255 143 1993 

  6. Cancer Res. BROWN L.F. 4727 53 1993 

  7. Brown, Lawrence F, Berse, Brygida, Jackman, Robert W, Tognazzi, Kathi, Guidi, Anthony J, Dvorak, Harold F, Senger, Donald R, Connolly, James L, Schnitt, Stuart J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human pathology, vol.26, no.1, 86-91.

  8. Daly, Tom, Royal, Richard E, Kershaw, Michael H, Treisman, Jonathan, Wang, Gang, Li, Weiping, Herlyn, Dorothee, Eshhar, Zelig, Hwu, Patrick. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene. Cancer gene therapy, vol.7, no.2, 284-291.

  9. de Vries, C, Escobedo, JA, Ueno, H, Houck, K, Ferrara, N, Williams, LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, vol.255, no.5047, 989-991.

  10. Ergün, S, Kiliç, N, Fiedler, W, Mukhopadhyay, A.K. Vascular endothelial growth factor and its receptors in normal human testicular tissue. Molecular and cellular endocrinology, vol.131, no.1, 9-20.

  11. Guerrin, Marina, Moukadiri, Hafida, Chollet, Pascale, Moro, Fraņoise, Dutt, Kamla, Malecaze, Fraņois, Plouët, Jean. Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultued in vitro. Journal of cellular physiology, vol.164, no.2, 385-394.

  12. Hanahan, Douglas, Folkman, Judah. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis. Cell, vol.86, no.3, 353-364.

  13. Holliger, P, Prospero, T, Winter, G. "Diabodies": small bivalent and bispecific antibody fragments.. Proceedings of the National Academy of Sciences of the United States of America, vol.90, no.14, 6444-6448.

  14. Cancer Res. HWU P. 3369 55 1995 

  15. 10.1016/S0065-2776(08)60623-9 

  16. Kim, K. Jin, Li, Bing, Winer, Jane, Armanini, Mark, Gillett, Nancy, Phillips, Heidi S., Ferrara, Napoleone. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, vol.362, no.6423, 841-844.

  17. Krüssel, J S, Casañ, E M, Raga, F, Hirchenhain, J, Wen, Y, Huang, H Y, Bielfeld, P, Polan, M L. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium.. Molecular human reproduction, vol.5, no.5, 452-458.

  18. Lin, Pengnian, Buxton, Jake A., Acheson, Ann, Radziejewski, Czeslaw, Maisonpierre, Peter C., Yancopoulos, George D., Channon, Keith M., Hale, Laura P., Dewhirst, Mark W., George, Samuel E., Peters, Kevin G.. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proceedings of the National Academy of Sciences of the United States of America, vol.95, no.15, 8829-8834.

  19. Lu, Dan, Kotanides, Helen, Jimenez, Xenia, Zhou, Qinwei, Persaud, Kris, Bohlen, Peter, Witte, Larry, Zhu, Zhenping. Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2. Journal of immunological methods, vol.230, no.1, 159-171.

  20. Clin. Cancer Res. MATSUNO F. 371 5 1999 

  21. J. Virol. MILLER A.D. 2220 65 1991 10.1128/JVI.65.5.2220-2224.1991 

  22. Moritz, D, Wels, W, Mattern, J, Groner, B. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.. Proceedings of the National Academy of Sciences of the United States of America, vol.91, no.10, 4318-4322.

  23. Pardoll, D M. Paracrine Cytokine Adjuvants in Cancer Immunotherapy. Annual review of immunology, vol.13, 399-415.

  24. Pasqualini, Renata, Koivunen, Erkki, Ruoslahti, Erkki. αv Integrins as receptors for tumor targeting by circulating ligands. Nature biotechnology, vol.15, no.6, 542-546.

  25. Cancer Res. RAN S. 4646 58 1998 

  26. Robertson, Miranda. Proteasomes in the pathway. Nature, vol.353, no.6342, 300-301.

  27. Schwartzentruber, D J, Hom, S S, Dadmarz, R, White, D E, Yannelli, J R, Steinberg, S M, Rosenberg, S A, Topalian, S L. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.12, no.7, 1475-1483.

  28. Takahashi, Morio, Kawabe, Takao, Ogura, Keiji, Maeda, Shin, Mikami, Yasuyo, Kaneko, Nobuyuki, Terano, Akira, Omata, Masao. Expression of Vascular Endothelial Growth Factor at the Human Gastric Ulcer Margin and in Cultured Gastric Fibroblasts: A New Angiogenic Factor for Gastric Ulcer Healing. Biochemical and biophysical research communications, vol.234, no.2, 493-498.

  29. Oncogene TERMAN B.I. 1677 6 1991 

  30. Terman, Bruce I., Dougher-Vermazen, Maureen, Carrion, Miguel E., Dimitrov, Dragan, Armellino, Douglas C., Gospodarowicz, Denis, Böhlen, Peter. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochemical and biophysical research communications, vol.187, no.3, 1579-1586.

  31. Blood TREISMAN J. 139 85 1995 10.1182/blood.V85.1.139.bloodjournal851139 

  32. Walter, Elizabeth A., Greenberg, Philip D., Gilbert, Mark J., Finch, Rosalynde J., Watanabe, Käthe S., Thomas, E. Donnall, Riddell, Stanley R.. Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor. The New England journal of medicine, vol.333, no.16, 1038-1044.

  33. J. Immunol. WEIJTENS M.E. 836 157 1996 10.4049/jimmunol.157.2.836 

  34. J. Immunol. YEE C. 4079 157 1996 10.4049/jimmunol.157.9.4079 

  35. Cancer Res. ZHU Z. 3209 58 1998 

  36. Ziegler, B. L., Valtieri, M., Porada, G. Almeida, Maria, R. De, Müller, R., Masella, B., Gabbianelli, M., Casella, I., Pelosi, E., Bock, T., Zanjani, E. D., Peschle, C.. KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells. Science, vol.285, no.5433, 1553-1558.

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로